@ARTICLE{
author={Brandt Christian,Fabo D,Milovanovic Maja S,Alvarez-Baron E,Thangavelu K,Milanov Ivan},
year={2023},
title={Number of seizure-free days with adjunctive cenobamate: post-hoc analysis of an open-label extension study},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={171-171},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Brandt C,Serratosa J,Villanueva V,Milanov Ivan,Milovanovic M,Alvarez-Baron E,Steinhoff B},
year={2022},
title={Clinical characteristics of patients achieving seizure freedom in a phase 2 trial evaluating adjunctive cenobamate},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={29},
number={},
pages={402-402},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Krauss Gregory L,Klein Pavel,Brandt Christian,Lee Sang Kun,Milanov Ivan,Milovanovic Maja S,Steinhoff Bernhard J,Kamin Marc},
year={2020},
title={Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures Reply},
journal={LANCET NEUROLOGY},
volume={19},
number={4},
pages={288-289},
document_type={Letter},
} 

@ARTICLE{
author={Krauss Gregory L,Klein Pavel,Brandt Christian,Lee Sang Kun,Milanov Ivan,Milovanovic Maja S,Steinhoff Bernhard J,Kamin Marc},
year={2020},
title={Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial},
journal={LANCET NEUROLOGY},
volume={19},
number={1},
pages={38-48},
document_type={Article},
} 

@ARTICLE{
author={Pugliatti Maura,Rosati G,Carton H,Riise Trond,Drulovic Jelena S,Vecsei L,Milanov Ivan},
year={2006},
title={The epidemiology of multiple sclerosis in Europe},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={13},
number={7},
pages={700-722},
document_type={Review},
}